RGCC Group Cancer Therapy, Tests & Liquid Biopsy Tests Explained

A tumour consists of several subsets of cells, each with different features. One of these subsets – called cancer stem cell-like cells, or tumour-initiating cells – drives how the disease progresses, whether a tumour is resistant to treatment, and the likelihood of relapse.

The aim of cancer treatment is to destroy cancer cells. When a patient is treated the majority of the cancer cells are destroyed, but some may still remain, in remission.

While a patient is in remission, the remaining cancer stem cells that survive treatment may spread to other parts of the body. So doctors need to detect, discover and explore the features of the remaining cancer stem cells. Our tests are used to detect in which cases the [remaining] cancer cells may respond to treatment. This is to reduce the risk of relapse, and have ways to treat these cancer cells in the future.

Need help?

Can brain tumours also be tested with a blood sample?

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

Which test is the most comprehensive test?

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

How do online consultations work?

Our global team of cancer experts are on hand to provide support and advice to both patients and fellow RGCC clinicians. It’s very simple:

Head to the Cancer A-Z app and navigate to the “Consultations” area.
You will be asked to complete a short online questionnaire to give us more information about your current concerns or requirements.
You will browse a shortlist of RGCC Network clinicians who can best help your needs.
Select your chosen consultant and then select your preferred consultation date and time using our interactive calendar.
You will receive a notification in our secure messaging area to confirm your appointment. If your consultant requires additional information before your meeting, they will contact you via the secure messaging area.

Do online consultations take place via Zoom, Skype or another method?

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Didn't find an answer to your question? Contact us directly.

Get in touch

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more

Cookies